It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Population health research is increasingly focused on the genetic determinants of healthy ageing, but there is no public resource of whole genome sequences and phenotype data from healthy elderly individuals. Here we describe the first release of the Medical Genome Reference Bank (MGRB), comprising whole genome sequence and phenotype of 2570 elderly Australians depleted for cancer, cardiovascular disease, and dementia. We analyse the MGRB for single-nucleotide, indel and structural variation in the nuclear and mitochondrial genomes. MGRB individuals have fewer disease-associated common and rare germline variants, relative to both cancer cases and the gnomAD and UK Biobank cohorts, consistent with risk depletion. Age-related somatic changes are correlated with grip strength in men, suggesting blood-derived whole genomes may also provide a biologic measure of age-related functional deterioration. The MGRB provides a broadly applicable reference cohort for clinical genetics and genomic association studies, and for understanding the genetics of healthy ageing.
Healthspan and healthy aging are areas of research with potential socioeconomic impact. Here, the authors present the Medical Genome Reference Bank (MGRB) which consist of over 4,000 individuals aged 70 years and older without a history of the major age-related diseases and report on results from whole-genome sequencing and association analyses.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); University of New South Wales, Children’s Cancer Institute, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of New South Wales, School of Women’s and Children’s Health, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
2 Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
3 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924)
4 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); University of New South Wales, Children’s Cancer Institute, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of New South Wales, School of Women’s and Children’s Health, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of New South Wales, St Vincent’s Clinical School, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
5 Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Uppsala University, Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457)
6 Georgia Institute of Technology, Center for Integrative Genomics, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)
7 Sax Institute, Sydney, Australia (GRID:grid.474225.2) (ISNI:0000 0004 0601 4585)
8 University of Sydney, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
9 University of New South Wales, Centre for Primary Health Care and Equity, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
10 Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); University of Tasmania, Menzies Institute for Medical Research, Hobart, Australia (GRID:grid.1009.8) (ISNI:0000 0004 1936 826X)
11 Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Curtin University, School of Public Health, Perth, Australia (GRID:grid.1032.0) (ISNI:0000 0004 0375 4078)
12 Hennepin Healthcare, Berman Center for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Minneapolis, USA (GRID:grid.414021.2) (ISNI:0000 0000 9206 4546); Hennepin County Medical Center and University of Minnesota, Division of Geriatrics, Department of Medicine, Minneapolis, USA (GRID:grid.414021.2) (ISNI:0000 0000 9206 4546)
13 Rush University Medical Center, Department of Family Medicine and Rush Alzheimer’s Disease Center, Chicago, USA (GRID:grid.240684.c) (ISNI:0000 0001 0705 3621)
14 The University of Newcastle, School of Biomedical Sciences and Pharmacy, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Hunter Medical Research Institute, Centre for Brain and Mental Health Research, Newcastle, Australia (GRID:grid.413648.c)
15 University of New South Wales, School of Psychiatry, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Neuroscience Research Australia, Sydney, Australia (GRID:grid.250407.4) (ISNI:0000 0000 8900 8842)
16 University of New South Wales, School of Psychiatry, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Neuroscience Research Australia, Sydney, Australia (GRID:grid.250407.4) (ISNI:0000 0000 8900 8842); Monash University, Department of Psychiatry, School of Clinical Sciences, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
17 Peter MacCallum Cancer Centre, Parkville Familial Cancer Centre, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000000403978434); University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
18 University of New South Wales, UNSW Cellular Genomics Futures Institute, School of Medical Sciences, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Garvan Institute of Medical Research, Garvan-Weizmann Centre for Cellular Genomics, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924)
19 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); University of New South Wales, St Vincent’s Clinical School, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
20 Uppsala University, Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457)
21 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); University of New South Wales, School of Biotechnology and Biomolecular Sciences, Faculty of Science, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)